FI91961B - Process for producing (S) -ethyl-2-oxo-1-pyrrolidine acetamide - Google Patents
Process for producing (S) -ethyl-2-oxo-1-pyrrolidine acetamide Download PDFInfo
- Publication number
- FI91961B FI91961B FI895562A FI895562A FI91961B FI 91961 B FI91961 B FI 91961B FI 895562 A FI895562 A FI 895562A FI 895562 A FI895562 A FI 895562A FI 91961 B FI91961 B FI 91961B
- Authority
- FI
- Finland
- Prior art keywords
- ethyl
- oxo
- methylthio
- pyrrolidineacetamide
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
9196191961
Menetelmä (S)-a-etyyli-2-okso-l-pyrrolidiiniasetamidin valmistamiseksi - Förfarande för tillverkning av (S)-a-etyl-2-oxo-1-pyrrolidinacetamidProcess for the preparation of (S) -α-ethyl-2-oxo-1-pyrrolidineacetamide - Preparation of (S) -α-ethyl-2-oxo-1-pyrrolidineacetamide
Keksintö koskee uutta menetelmää (S)-a-etyyli-2-okso-l-pyrro-lidiiniasetamidin valmistamiseksi, jolla on kaava O-·The invention relates to a new process for the preparation of (S) -α-ethyl-2-oxo-1-pyrrolidineacetamide of the formula O- ·
NOF
^ c CH,-CH7'^ / \ / conh2^ c CH, -CH7 '^ / \ / conh2
HB
Saman hakijan US-patenttijulkaisussa 4696943 ja 4837223 kuvataan tämä yhdiste, jolla on absoluuttinen konfiguraatio (S) ja esitetään, että sillä on erityisiä terapeuttisia ominaisuuksia, jotka poikkeavat täysin odottamattomalla tavalla raseemi-sen muodon ominaisuuksista. Ominaisuuksiensa ansiosta S-enan-tiomeeri on raseemista muotoa sopivampi keskushermoston hapen-niukkuudesta ja vähäverisyydestä johtuvien aggressioiden hoitoon ja ennaltaestoon.U.S. Patent Nos. 4,696,943 and 4,837,223 to the same applicant describe this compound having the absolute configuration (S) and show that it has specific therapeutic properties that are completely unexpectedly different from those of the racemic form. Due to its properties, the S-enan thiomer is more suitable than the racemic form for the treatment and prevention of aggressions due to hypoxia and anemia of the central nervous system.
(S)-a-etyyli-2-okso-l-pyrrolidiiniasetamidin valmistus on : kuvattu edellä mainituissa US-patenttijulkaisuissa 4696943 ja 4837223. Näiden patenttijulkaisujen mukaan yhdistettä ei voida saada suoraan raseemisesta seoksesta kahden enantiomeerin erotuksella. Se on valmistettava muulla tavoin, ja näissä US-patentti julkaisuissa kuvataan 2 menetelmää yhdisteen valmistamiseksi. Ensimmäisessä menetelmässä (S)-a-etyyli-2-okso-l-pyrro-lidiinietikkahappo saatetaan vaiheittain reagoimaan alkyyliha-logeeniformiaatin, edullisesti etyyliklooriformiaatin, ja ammoniakin kanssa. Toisessa menetelmässä syklisoidaan alkyyli- (S)-4-[[2-(aminokarbonyyli)propyyli]amino]butyraatti tai (S)-N-[1-(aminokarbonyyli)propyyli]-4-halogeenibutanamidi, näiden 91961 2 2 yhdisteen itsensä valmistuksen tapahtuessa (S)-aminobutan-amidista.The preparation of (S) -α-ethyl-2-oxo-1-pyrrolidineacetamide is: described in the aforementioned U.S. Patent Nos. 4,696,943 and 4,837,223. According to these patents, a compound cannot be obtained directly from a racemic mixture by separation of two enantiomers. It must be prepared in another way, and these U.S. patent publications describe 2 methods for preparing a compound. In the first method, (S) -α-ethyl-2-oxo-1-pyrrolidineacetic acid is reacted stepwise with an alkyl haloformate, preferably ethyl chloroformate, and ammonia. In another method, alkyl (S) -4 - [[2- (aminocarbonyl) propyl] amino] butyrate or (S) -N- [1- (aminocarbonyl) propyl] -4-halobutanamide is cyclized to prepare 91961 2 2 of the compound itself. in the case of (S) -aminobutanamide.
Näille kahdelle menetelmälle on yhteistä sama haitta. Molemmat vaativat lähtöainereaktantin valmistusta, jolla jo on oikea stereokemiallinen konfiguraatio. Tämä lähtöaine saadaan resoluutiolla vastaavasta raseemisesta yhdisteestä, raseemisesta (±)-a-etyyli-2-okso-l-pyrrolidiinietikkahaposta ensimmäisen menetelmän kohdalla, ja (±)-2-aminobutaaniamidista toisen menetelmän kohdalla. Halutun konfiguraation omaavan enan-tiomeerin tarvittava esierotus aiheuttaa alusta lähtien käytetyn lähtöaineen 50 % menetyksen. Edelleen, mikäli otetaan huomioon, että optisen isomeerin talteenotto suoritetaan harvoin kvantitatiivisella saannolla, on raaka-aineen koko-naishävikki paljon yli 50 % raseemisesta lähtöaineesta.The two methods have the same disadvantage in common. Both require the preparation of a starting material reactant that already has the correct stereochemical configuration. This starting material is obtained by resolution of the corresponding racemic compound, racemic (±) -α-ethyl-2-oxo-1-pyrrolidineacetic acid for the first method, and (±) -2-aminobutanamide for the second method. The necessary pre-separation of the enantiomer of the desired configuration results in a 50% loss of the starting material used from the beginning. Furthermore, given that the recovery of the optical isomer is rarely performed in quantitative yield, the total loss of raw material is well over 50% of the racemic starting material.
Menetelmä, jolla ei olisi tätä haittaa, samalla kun se olisi suhteellisen helppo suorittaa, olisi erittäin toivottava.A method that would not have this disadvantage while being relatively easy to perform would be highly desirable.
Tämä keksintö järjestää siten uuden menetelmän, jolla ei ole edellisten menetelmien haittaa, ja joka, seurauksena, on taloudellisempi. Edelleen, tällä uudella menetelmällä on myös etuna, että lähtöaineena käytetään luonnollisesti esiintyvää aminohappoa, L-mentioniinia tai sen helposti saatavaa amidia.The present invention thus provides a new method which does not have the disadvantage of the previous methods and which, as a result, is more economical. Furthermore, this new method also has the advantage of using a naturally occurring amino acid, L-mentionin or an readily available amide thereof as a starting material.
Keksinnön mukainen menetelmä (S) -Of-etyyli-2-okso-l-pyrroli- diiniasetamidin valmistamiseksi, käsittää (S)-a-(metyylitio)-etyyli]-2-okso-l-pyrrolidiiniasetamidin hydrogenolyysin desul-furointireagenssin avulla seuraavan reaktioyhtälön mukaisestiThe process of the invention for the preparation of (S) -Of-ethyl-2-oxo-1-pyrrolidineacetamide comprises the hydrogenation of (S) -α- (methylthio) -ethyl] -2-oxo-1-pyrrolidineacetamide with a desulfurization reagent according to the following reaction equation in accordance with
N NN N
I -> II -> I
^ c ^ - c CH3SCH2CH£" \ ch3-ch2"^ i \ / conh2 / conh2^ c ^ - c CH3SCH2CH £ "\ ch3-ch2" ^ i \ / conh2 / conh2
H HH H
91961 3 (S)-a-[2-(metyylitio)etyyli]-2-okso-l-pyrrolidiiniasetamidin desulfurointi on stereoselektiivinen. Reaktio suoritetaan yleensä vedessä lämpötilassa 50 - 100°C desulfurointireagens-sin, kuten NaBH4/NiCl2 ’ 6H20:n (R.B. Boar et ai. , J. Chem. Soc. , Perkin Trans. I (1973), s. 654), Raney-nikkeli W-2:n, tai edullisesti Raney-nikkeli T-l:n läsnäollessa normaali- tai korotetussa paineessa (X. Dominiguez et ai., J. Org. Chem. 26 (1961), s. 1625).91961 Desulfurization of 3 (S) -α- [2- (methylthio) ethyl] -2-oxo-1-pyrrolidineacetamide is stereoselective. The reaction is generally carried out in water at a temperature of 50 to 100 ° C with a desulfurization reagent such as NaBH 4 / NiCl 2 • 6H 2 O (RB Boar et al., J. Chem. Soc., Perkin Trans. I (1973), p. 654), Raney nickel W-2, or preferably Raney nickel T1 at normal or elevated pressure (X. Dominiguez et al., J. Org. Chem. 26 (1961), p. 1625).
(S) -a-[2-(metyylitio)etyyli]-2-okso-l-pyrrolidiiniasetamidi, joka on tämän menetelmän lähtöaine, on uusi yhdiste. Se voidaan valmistaa jommalla kummalla seuraavista 2 menetelmästä: 1) saattamalla (S)-2-amino-4-(metyylitio)butanamidihydroklori-di reagoimaan kaavan HalCH2CH2CH2COHal mukaisen halogeenibuty-ryylihalogenidin kanssa, jossa Hai on halogeeniatomi, edullisesti klooriatomi, seuraavan reaktioyhtälön mukaisesti:(S) -α- [2- (methylthio) ethyl] -2-oxo-1-pyrrolidineacetamide, which is the starting material of this process, is a novel compound. It can be prepared by one of the following 2 methods: 1) by reacting (S) -2-amino-4- (methylthio) butanamide hydrochloride with a halobutyl halide of the formula HalCH 2 CH 2 CH 2 COHal, wherein Hal is a halogen atom, preferably a chlorine atom, according to the following reaction equation:
NH2·HC1 I \=ONH2 · HCl I \ = O
I Hal-CH2CH2CH2COHalI Hal-CH2CH2CH2COHal
I -> II -> I
^ ^ C KOH ^ C^ ^ C KOH ^ C
ch3sch2ch2" / \ ch3sch2ch^ / \ / conh2 / conh2ch3sch2ch2 "/ \ ch3sch2ch ^ / \ / conh2 / conh2
H HH H
Tämä reaktio suoritetaan tavallisesti inertissä liuottimessa, esimerkiksi dikloorimetaanissa, lämpötilassa no in 0°C katalysaattorin kuten tetrahydrobutyyliammoinumbromidin läsnäollessa jauhemaisen kaiiumhydroksidin läsnäollessa.This reaction is usually carried out in an inert solvent, for example dichloromethane, at a temperature of about 0 ° C in the presence of a catalyst such as tetrahydrobutylammonium bromide in the presence of powdered potassium hydroxide.
2) a) saattamalla ensin (S)-2-amino-4-(metyylitio)butanamidi reagoimaan kaavan XCH2CH2CH2COOR mukaisen 4-halogeenibutyraa-tin kanssa, jossa X on halogeeniatomi ja R on alkyyliradikaa-li, jossa on 1 - 4 hiiliatomia, seuraavan reaktioyhtälön mukaisesti: 4 91961 r\ nh2 nh )= 0 I XCH2CH2CH2COOR I /2) a) by first reacting (S) -2-amino-4- (methylthio) butanamide with a 4-halobutyrate of formula XCH 2 CH 2 CH 2 COOR wherein X is a halogen atom and R is an alkyl radical having 1 to 4 carbon atoms, the following according to the reaction equation: 4 91961 r \ nh2 nh) = 0 I XCH2CH2CH2COOR I /
I -> I ORI -> I OR
CV -CCV -C
CH3SCH3CH2" / \ CH3SCH2CH2"" / \ / conh2 / conh2CH3SCH3CH2 "/ \ CH3SCH2CH2" "/ \ / conh2 / conh2
H HH H
Tämä reaktio suoritetaan tavallisesti kuumentamalla useita tunteja lämpötilassa 80 - 100°C inertissä liuottimessa kuten tolueenissa hapon vastaanottajan kuten tertiäärisen orgaanisen emäksen kuten esimerkiksi trietyyliamiinin läsnäollessa.This reaction is usually carried out by heating for several hours at 80 to 100 ° C in an inert solvent such as toluene in the presence of an acid acceptor such as a tertiary organic base such as triethylamine.
b) syklisoimalla sitten vaiheessa a) saatu (S)-4-[[1-(amino-karbonyyli)-3-(metyylitio)propyyli]amino]butyraatti seuraavan kaavan mukaisesti: n n.b) then cyclizing the (S) -4 - [[1- (aminocarbonyl) -3- (methylthio) propyl] amino] butyrate obtained in step a) according to the following formula: n.
NH 1=0 ^fc= 0NH 1 = 0 ^ fc = 0
I / NY / N
I OR -> II OR -> I
^ C ^ - c ch3sch2ch2" ' / \ ch3sch2ch^ ' J \ : / conh2 / conh2^ C ^ - c ch3sch2ch2 "'/ \ ch3sch2ch ^' J \: / conh2 / conh2
H HH H
Tämä syklisointi suoritetaan tavallisesti inertissä liuottimessa, kuten esimerkiksi tolueenissa tai ksyleenissä, kuumentamalla lämpötilassa välillä 100 ja 130°C useita tunteja katalysaattorin, kuten 2-hydroksipyridiinin läsnäollessa.This cyclization is usually carried out in an inert solvent such as toluene or xylene by heating at a temperature between 100 and 130 ° C for several hours in the presence of a catalyst such as 2-hydroxypyridine.
(S)-2-amino-4-(metyylitio)butanamidi, vapaana emäksenä, voidaan valmistaa L-metioniinista menetelmän mukaisesti, jonka ovat kuvanneet: E. Sandrin ja R.A. Boissonnas; Helv. Acta, 46 (1963), s. 1637 - 1669.(S) -2-Amino-4- (methylthio) butanamide, as the free base, can be prepared from L-methionine according to the method described by: E. Sandrin and R.A. Boissonnas; Helv. Acta, 46 (1963), pp. 1637-1669.
Sp. : 50 - 51°C. [a] d2 = -27,7° (c = 2, dimetyyliformamidi) .Sp. : 50 - 51 ° C. [α] D 20 = -27.7 ° (c = 2, dimethylformamide).
Il 91961 5 (S)-2-amino-4-(metyylitiö)butanamidihydrokloridi, joka on tunnettu yhdiste, voidaan valmistaa emäksestä menetelmällä, jonka on kuvanneet: A. Eberle et. ai.: Helv. Chim. Acta, 61, (1978), s. 2360 - 2374.Il 91961 5 (S) -2-Amino-4- (methylthio) butanamide hydrochloride, a known compound, can be prepared from a base by the method described by A. Eberle et. ai .: Helv. Chim. Acta, 61, (1978), pp. 2360-2374.
Sp. : 212 - 215°C. [a] = +26,4° (c = 2, dimetyyliformamidi) .Sp. : 212 - 215 ° C. [α] = + 26.4 ° (c = 2, dimethylformamide).
Seuraava esimerkki esitetään keksinnön kuvaamismielessä.The following example is presented to illustrate the invention.
Tässä esimerkissä lopputuotteen optinen puhtaus varmistettiin kalorimetrisellä differentiaalientalpioiden määrityksellä (C. Fouquey ja J. Jacques, Tetrahedron, 23, (1967),In this example, the optical purity of the final product was confirmed by calorimetric determination of differential enthalpies (C. Fouquey and J. Jacques, Tetrahedron, 23, (1967)).
Esimerkki I. Lähtöaine (S)-a-[2-(metyylitio)etyyli]-2-okso-l-pyrrolidii-niasetamidin valmistus 1) 4-halogeenibutyryylihalogenidista 84 g vedetöntä natriumsulfaattia lisätään suspensioon, jossa on 92,22 g (0,5 mol) S-2-amino-4-(metyylitio)butanamidia 600 ml:ssa dikloorimetaania huoneen lämpötilassa. Sitten seos jäähdytetään 0°C:een ja suspensioon lisätään 115 g jauhettua kaliumhydroksidia ja 8,1 g (0,025 mol) tetrabutyyliammonium-bromidia liuotettuna 100 ml:aan dikloorimetaania. Lisätään ί tipoittain samassa lämpötilassa voimakkaasti sekoittaen liuos, joka sisältää 77,5 g (0,55 mol) 4-klooributyryylikloridia 100 ml:ssa dikloorimetaania. Reaktioväliaine laimennetaan lisäyksen aikana samanaikaisesti 550 ml:n dikloorimetaanin lisäyksellä. 2 h sekoituksen jälkeen 0°C:ssa seokseen lisätään 29 g jauhettua kaliumhydroksidia. 4,5 h reaktion kuluttua lisätään edelleen 29 g jauhettua kaliumhydroksidia, ja sekoitusta jatketaan 1 h 0°C:ssa. Sitten reaktioseos suodatetaan Hyflocelillä, ja suodos haihdutetaan alipaineessa. Jäännös puhdistetaan kromatografoimalla silikageelillä (eluentti: dikloorimetaani/metanoii/ammoniakki-seos 95,5:4,5:0,2, tilavuus). Saadaan 66 g (S) -or- [2-(metyylitio) etyyli]-2-okso-l- 91*61 6 pyrrolidiiniasetamidia valkoisena jauheena, [a] Is = -39,1° (c = 1, metanoli)Example I. Preparation of starting material (S) -α- [2- (methylthio) ethyl] -2-oxo-1-pyrrolidineacetamide 1) 84 g of anhydrous sodium sulfate from 4-halobutyryl halide are added to a suspension of 92.22 g (0, 5 mol) of S-2-amino-4- (methylthio) butanamide in 600 ml of dichloromethane at room temperature. The mixture is then cooled to 0 [deg.] C. and 115 g of ground potassium hydroxide and 8.1 g (0.025 mol) of tetrabutylammonium bromide dissolved in 100 ml of dichloromethane are added to the suspension. A solution of 77.5 g (0.55 mol) of 4-chlorobutyryl chloride in 100 ml of dichloromethane is added dropwise at the same temperature with vigorous stirring. During the addition, the reaction medium is diluted simultaneously with 550 ml of dichloromethane. After stirring for 2 h at 0 ° C, 29 g of powdered potassium hydroxide are added to the mixture. After 4.5 h of the reaction, a further 29 g of powdered potassium hydroxide are added and stirring is continued for 1 h at 0 ° C. The reaction mixture is then filtered through Hyflocel, and the filtrate is evaporated under reduced pressure. The residue is purified by chromatography on silica gel (eluent: dichloromethane / methanol / ammonia 95.5: 4.5: 0.2, by volume). 66 g of (S) -or- [2- (methylthio) ethyl] -2-oxo-1-91 * 61 6 pyrrolidineacetamide are obtained in the form of a white powder, [α] D = -39.1 ° (c = 1, methanol)
Saanto: 61 %Yield: 61%
Alkuaineanalyysi : CgH^^C^S % : ina : laskettu: C 50,00; H 7,41; N 12,96 saatu: 50,15; 7,80 12,94 2) Alkyyli-4-halogeenibutyraatista a) Etyyli-(S)-4-[[1-(aminokarbonyyli)-3-(metyylitio)propyyli]-amino]butyraatti 10,57 ml (76 mmol) triamiinia lisätään 10 g (68 mmol) (S)-2-amino-4-(metyylitio)butamidin suspensioon 100 ml:ssa toluee-nia. Seos kuumennetaan 80 - 85°C:een kiivaasti sekoittaen, ja lisätään tipoittain 13,26 g (68 mmol) etyyli-4-bromibuty-raattia. Tätä lämpötilaa pidetään yllä 8 h. Sitten liuotin haihdutetaan alipaineessa ja jäännös otetaan 100 ml:aan di-kloorimetaania. Seosta refluksoidaan 30 min ja suodatetaan kuumana. Suodos haihdutetaan kuiviin ja saatu jäännös puhdistetaan kromatografoimalla silikageelillä (eluentti: etyyli-asetaatti/metanoli/ammoniakki-seos 10:0,1:0,1, tilavuus). Näin saadaan 6,2 g etyyli-(S)-4-[[1-(aminokarbonyyli)-4-(metyylitio) propyyli]amino]butyraattia.Elemental analysis: C 9 H 18 Cl 2 S%: Calculated: C 50.00; H 7.41; N 12.96 Found: 50.15; 7.80 12.94 2) Alkyl 4-halobutyrate a) Ethyl (S) -4 - [[1- (aminocarbonyl) -3- (methylthio) propyl] amino] butyrate 10.57 ml (76 mmol) triamine is added to a suspension of 10 g (68 mmol) of (S) -2-amino-4- (methylthio) butamide in 100 ml of toluene. The mixture is heated to 80-85 ° C with vigorous stirring, and 13.26 g (68 mmol) of ethyl 4-bromobutyrate are added dropwise. This temperature is maintained for 8 h. The solvent is then evaporated off under reduced pressure and the residue is taken up in 100 ml of dichloromethane. The mixture is refluxed for 30 min and filtered hot. The filtrate is evaporated to dryness and the residue obtained is purified by chromatography on silica gel (eluent: ethyl acetate / methanol / ammonia 10: 0.1: 0.1, by volume). 6.2 g of ethyl (S) -4 - [[1- (aminocarbonyl) -4- (methylthio) propyl] amino] butyrate are thus obtained.
[a] H6 = -14,1° (c = 1, metanoli) * Saanto: 35 % Tätä välituoteyhdistettä käytetään sellaisenaan ilman lisäpuh-distusta lopullisen syklisoinnin suoritukseen.[α] H 6 = -14.1 ° (c = 1, methanol) * Yield: 35% This intermediate is used as such without further purification to carry out the final cyclization.
b) 0,6 g (2,29 mmol) kohdassa a) saatua raakatuotetta ja » 21,3 mg (0,225 mmol) 2-hydroksipyridiiniä sekoitetaan 1,15 ml:ssa p-ksyleeniä. Seosta kuumennetaan 130°C:ssa typen alla 4,5 h. Sitten se jäähdytetään ja sekoitetaan 30 min huoneen lämpötilassa. Muodostuva sakka suodatetaan ja uudel-leenkiteytetään etyyliasetaatista. Saadaan 0,18 g (S)-a-[2-(metyylitio)etyyli]-2-okso-l-pyrrolidiiniasetamidia.b) 0.6 g (2.29 mmol) of the crude product obtained in a) and »21.3 mg (0.225 mmol) of 2-hydroxypyridine are mixed in 1.15 ml of p-xylene. The mixture is heated at 130 ° C under nitrogen for 4.5 h. It is then cooled and stirred for 30 min at room temperature. The precipitate formed is filtered off and recrystallized from ethyl acetate. 0.18 g of (S) -α- [2- (methylthio) ethyl] -2-oxo-1-pyrrolidineacetamide is obtained.
n 91961 7 [α] π5 = -36,5° (c = 1, metanoli)n 91961 7 [α] π5 = -36.5 ° (c = 1, methanol)
Saanto: 36 %Yield: 36%
Alkuaineanalyysi: C9Hi6N2°2S % : ina : laskettu: C 50,00; H 7,41; N 12,96 saatu: 49,88; 7,49 12,68 II. (S)-a-etyyli-2-okso-l-pyrrolidiiniasetamidin valmistus 50 g Raney-nikkeliä T-l (X.A. Bominiguez et al., J. Org. Chem.Elemental analysis: C 9 H 16 N 2 O 2 S%: Calculated: C 50.00; H 7.41; N 12.96 Found: 49.88; 7.49 12.68 II. Preparation of (S) -α-ethyl-2-oxo-1-pyrrolidineacetamide 50 g of Raney nickel T-1 (X.A. Bominiguez et al., J. Org. Chem.
26, (1961), s. 1625), 386 ml vettä ja 7 g (0,0324 mol) (S)-a- [2-(metyylitiö)etyyli]-2-okso-l-pyrrolidiiniasetamidia lisätään peräjälkeen 1-1 kolmikaulapyöreäpohjäiseen pulloon. Seos kuumennetaan 75°C:een ja sekoitetaan tässä lämpötilassa 1 h.26, (1961), p. 1625), 386 ml of water and 7 g (0.0324 mol) of (S) -α- [2- (methylthio) ethyl] -2-oxo-1-pyrrolidineacetamide are added successively in 1-1 in a three-necked round-bottomed flask. The mixture is heated to 75 ° C and stirred at this temperature for 1 h.
Se suodatetaan ja vesi haihdutetaan pois alipaineessa. Jäännös (5,3 g) uudelleenkiteytetään 60 ml:sta etyyliasetaattia. Saadaan 3,86 g (S)-a-etyyli-2-okso-l-pyrrolidiiniasetamidia.It is filtered and the water is evaporated off under reduced pressure. The residue (5.3 g) is recrystallized from 60 ml of ethyl acetate. 3.86 g of (S) -α-ethyl-2-oxo-1-pyrrolidineacetamide are obtained.
Sp.: 112 - 115°C. [a]£s = -90° (c = 1, asetoni)M.p .: 112-115 ° C. [α] D = -90 ° (c = 1, acetone)
Saanto: 69 %Yield: 69%
Alkuaineanalyysi: C8H14N202 %:ina: laskettu: C 56,45; H 8,29; N 16,46 saatu: 56,30; 8,42 16,18 «Elemental analysis: C 8 H 14 N 2 O 2%: Calculated: C 56.45; H 8.29; N 16.46 Found: 56.30; 8.42 16.18 «
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888827389A GB8827389D0 (en) | 1988-11-23 | 1988-11-23 | Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
GB8827389 | 1988-11-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI895562A0 FI895562A0 (en) | 1989-11-22 |
FI91961B true FI91961B (en) | 1994-05-31 |
FI91961C FI91961C (en) | 1994-09-12 |
Family
ID=10647345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI895562A FI91961C (en) | 1988-11-23 | 1989-11-22 | Process for the preparation of (S) -ethyl-2-oxo-1-pyrrolidineacetamide |
Country Status (17)
Country | Link |
---|---|
KR (1) | KR0157610B1 (en) |
CN (1) | CN1020604C (en) |
AT (1) | AT392781B (en) |
BG (1) | BG51041A3 (en) |
CY (1) | CY1672A (en) |
ES (1) | ES2023532A6 (en) |
FI (1) | FI91961C (en) |
GB (2) | GB8827389D0 (en) |
GR (1) | GR1000719B (en) |
HK (1) | HK102492A (en) |
HU (1) | HU204508B (en) |
NO (1) | NO173823C (en) |
PH (1) | PH26332A (en) |
PL (1) | PL161781B1 (en) |
PT (1) | PT92365B (en) |
RU (1) | RU1797607C (en) |
SG (1) | SG89392G (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9319732D0 (en) | 1993-09-24 | 1993-11-10 | Ucb Sa | Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety |
US6107492A (en) * | 1998-05-08 | 2000-08-22 | Ucb, S.A. | Process for the preparation of levetiracetam |
ES2287039T3 (en) | 1999-12-01 | 2007-12-16 | Ucb, S.A. | A PIRROLIDINACETAMIDE DERIVATIVE FOR THE TREATMENT OF CHRONIC OR NEUROPATHIC PAIN. |
GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
US7132552B2 (en) * | 2003-02-03 | 2006-11-07 | Teva Pharmaceutical Industries, Ltd. | Process for producing levetiracetam |
ES2214147B1 (en) * | 2003-02-28 | 2005-10-01 | Farma-Lepori S.A. | PROCEDURE FOR OBTAINING AN ANTIEPILEPTIC AGENT. |
PL1667967T3 (en) | 2003-09-24 | 2012-11-30 | Ucb Pharma Sa | Process for preparing 2-oxo-1-pyrrolidine derivatives |
CA2488325C (en) | 2004-11-22 | 2010-08-24 | Apotex Pharmachem Inc. | Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
AU2006254336B9 (en) | 2005-06-01 | 2013-02-28 | Ucb Pharma, S.A. | 2 -oxo-I -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system |
US8338621B2 (en) | 2005-12-21 | 2012-12-25 | Ucb S.A. | Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
WO2009050735A1 (en) * | 2007-10-15 | 2009-04-23 | Lupin Limited | A novel polymorph of levetiracetam and a process for its preparation |
EP2147911A1 (en) | 2008-07-24 | 2010-01-27 | ZaCh System S.p.A. | Process for the preparation of levetiracetam |
US7939676B2 (en) | 2009-09-17 | 2011-05-10 | Zach System S.P.A. | Process for the preparation of levetiracetam |
KR102461134B1 (en) | 2014-01-21 | 2022-10-28 | 얀센 파마슈티카 엔.브이. | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
UA121965C2 (en) | 2014-01-21 | 2020-08-25 | Янссен Фармацевтика Нв | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1309692A (en) * | 1970-02-13 | 1973-03-14 | Ucb Sa | N-substituted lactams |
GB8412358D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
-
1988
- 1988-11-23 GB GB888827389A patent/GB8827389D0/en active Pending
-
1989
- 1989-11-20 BG BG090398A patent/BG51041A3/en unknown
- 1989-11-20 GR GR890100769A patent/GR1000719B/en not_active IP Right Cessation
- 1989-11-21 PT PT92365A patent/PT92365B/en not_active IP Right Cessation
- 1989-11-21 GB GB8926244A patent/GB2225322B/en not_active Expired - Lifetime
- 1989-11-22 CN CN89108764A patent/CN1020604C/en not_active Expired - Fee Related
- 1989-11-22 AT AT2666/89A patent/AT392781B/en not_active IP Right Cessation
- 1989-11-22 RU SU4742434A patent/RU1797607C/en active
- 1989-11-22 NO NO894649A patent/NO173823C/en unknown
- 1989-11-22 HU HU896132A patent/HU204508B/en not_active IP Right Cessation
- 1989-11-22 ES ES8903978A patent/ES2023532A6/en not_active Expired - Lifetime
- 1989-11-22 FI FI895562A patent/FI91961C/en active IP Right Grant
- 1989-11-22 PL PL89282413A patent/PL161781B1/en unknown
- 1989-11-23 PH PH39568A patent/PH26332A/en unknown
- 1989-11-23 KR KR1019890017038A patent/KR0157610B1/en not_active IP Right Cessation
-
1992
- 1992-09-05 SG SG893/92A patent/SG89392G/en unknown
- 1992-12-17 HK HK1024/92A patent/HK102492A/en not_active IP Right Cessation
-
1993
- 1993-05-14 CY CY1672A patent/CY1672A/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO894649L (en) | 1990-05-25 |
GR1000719B (en) | 1992-11-23 |
GB8926244D0 (en) | 1990-01-10 |
PH26332A (en) | 1992-04-29 |
PT92365B (en) | 1995-07-18 |
BG51041A3 (en) | 1993-01-15 |
GB8827389D0 (en) | 1988-12-29 |
RU1797607C (en) | 1993-02-23 |
NO173823B (en) | 1993-11-01 |
KR900007797A (en) | 1990-06-02 |
HK102492A (en) | 1992-12-24 |
NO173823C (en) | 1994-02-09 |
AT392781B (en) | 1991-06-10 |
ATA266689A (en) | 1990-11-15 |
NO894649D0 (en) | 1989-11-22 |
GR890100769A (en) | 1990-12-31 |
CN1042904A (en) | 1990-06-13 |
HU204508B (en) | 1992-01-28 |
ES2023532A6 (en) | 1992-01-16 |
FI91961C (en) | 1994-09-12 |
PL161781B1 (en) | 1993-07-30 |
GB2225322A (en) | 1990-05-30 |
CY1672A (en) | 1993-05-14 |
GB2225322B (en) | 1992-03-25 |
SG89392G (en) | 1992-12-04 |
PT92365A (en) | 1990-05-31 |
KR0157610B1 (en) | 1998-11-16 |
HU896132D0 (en) | 1990-02-28 |
HUT53072A (en) | 1990-09-28 |
CN1020604C (en) | 1993-05-12 |
FI895562A0 (en) | 1989-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI91961B (en) | Process for producing (S) -ethyl-2-oxo-1-pyrrolidine acetamide | |
FI66847C (en) | FARING PROOF FOR 4-HYDROXY-2-OXO-PYRROLIDINAL CHANNEL | |
CA2455155C (en) | Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues | |
AU703927B2 (en) | 7-amino-2-heptenoates and their use in the preparation of methylphenidate | |
JP2017132793A (en) | Synthesis of R-biphenylalaninol | |
CA2497062A1 (en) | Preparation of amino acid amides | |
US20080227976A1 (en) | Process for synthesizing aspartic and glutamic acid derivatives especially useful as intermediates in the manufacture of a caspase inhibitor | |
Amedjkouh et al. | Synthesis of chiral diamines using novel 2-trichloromethyloxazolidin-4-one precursors derived from 5-oxo-proline and proline | |
WO1994026771A1 (en) | Process for the stereoselective preparation of l-alanyl-l-proline | |
Enders et al. | Enantioselective Synthesis of β‐Amino Sulfones by aza‐Michael Addition to Alkenyl Sulfones | |
US7256289B2 (en) | Process for making chiral 1,4-disubstituted piperazines | |
IE48209B1 (en) | Novel substituted heterocyclic benzamides and their production | |
IE56543B1 (en) | Process for preparing 4-amino-5-hexenoic acid | |
WO2006103696A2 (en) | Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives | |
Paradisi et al. | A new stereocontrolled synthesis of uncommon tripeptides derived from 2, 6-diaminopimelic acid (2, 6-DAP) | |
De et al. | Polyaniline supported cobalt catalysed one pot stereoselective synthesis of the structural analogues of aminopeptidase inhibitor Bestatin | |
US6977311B2 (en) | Process for synthesizing L-γ-methylene glutamic acid and analogs | |
US5252747A (en) | Chiral quinolone intermediates | |
ITMI981502A1 (en) | CHIRAL STATIONARY PHASES FOR THE SEPARATION OF ENANTIOMERS AND THEIR PREPARATION | |
CA2272664A1 (en) | Process for the preparation of 3-amino-2-oxo-pyrrolidines, novel intermediates and their use | |
US6689890B2 (en) | Efficient lactam synthesis | |
FI88723B (en) | / 2,5-DIHYDRO-2-OXO-5-PHENYL-3-FURANYL / AMINER SAMT DERAS ANVAENDNING VID FRAMSTAELLNING AV ACE-INHIBITORER | |
KR100305152B1 (en) | Manufacturing method of C-substituted diethylene triamine | |
JP2803879B2 (en) | Preparation of pyrrolidine derivatives | |
KR820002047B1 (en) | Process for preparing piperidine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Owner name: UCB S.A. |
|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: UCB S.A. |